ESP Block for Pain After Kidney Stone Surgery
Trial Summary
What is the purpose of this trial?
The purpose of this study is to investigate the use of the erector spinae (ESP) block in reducing the morphine milligram equivalent (MME) consumption post percutaneous nephrolithotomy. Objectives: 1. - Determine if there is a significant effect on post percutaneous nephrolithotomy MME consumption with the usage of an ESP block vs. saline control. 2. - Determine if there is a significant effect on reported pain levels with the use of an ESP block vs. saline control in post percutaneous nephrolithotomies.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you have been using opioids for more than 90 days in the past year, you cannot participate.
What data supports the idea that ESP Block for Pain After Kidney Stone Surgery is an effective treatment?
The available research shows that the Erector Spinae Plane Block (ESPB) is effective in managing pain after kidney stone surgery. One study found that patients who received ESPB had significantly lower pain scores at various times after surgery compared to those who did not receive the block. This suggests that ESPB provides better pain relief than standard intravenous pain medication. Additionally, patients who received ESPB were less agitated and had better breathing function after surgery, indicating additional benefits beyond pain relief.12345
What safety data is available for ESP block in kidney stone surgery?
The ESP block is described as a simple and safe method for postoperative analgesia in several studies. It is noted for its safety in providing analgesia after thoracolumbar surgeries and is considered an alternative to neuraxial block for post-surgical pain. However, specific safety data for ESP block in kidney stone surgery is not directly addressed in the provided research abstracts.12467
Research Team
Jason Buehler, MD
Principal Investigator
University of Tennessee Medical Center
Eligibility Criteria
This trial is for English-speaking adults over 18 who are having non-emergency kidney stone surgery (percutaneous nephrolithotomy) during weekdays. They must be able to understand and explain the consent process, and women of childbearing age need a negative pregnancy test.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo percutaneous nephrolithotomy and receive either an ESP block or a control block
Immediate Post-operative Monitoring
Participants are monitored for opioid consumption and pain levels using VAS scores in the first 24 hours post-surgery
Follow-up
Participants are monitored for recovery quality and opioid use at 24 hours, 48 hours, 7 days, and 30 days post-surgery
Treatment Details
Interventions
- Dexamethasone
- Erector Spinae Plane Block
- Ropivacaine 0.5% Injectable Solution
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Tennessee Medical Center
Lead Sponsor